|
Apigenin |
|
|
ALX-385-008-M010 |
|
10 mg |
35.00 USD |
|
 |
|
ALX-385-008-M050 |
|
50 mg |
105.00 USD |
|
|
|
|
Artemisinin |
|
|
ALX-350-219-M100 |
|
100 mg |
35.00 USD |
|
|
|
ALX-350-219-G001 |
|
1 g |
220.00 USD |
|
|
|
|
Chetomin |
|
|
ALX-350-128-M001 |
|
1 mg |
185.00 USD |
|
|
|
ALX-350-128-M005 |
|
5 mg |
495.00 USD |
|
|
|
|
Chrysin |
|
|
ALX-385-009-G001 |
|
1 g |
15.00 USD |
|
|
|
|
2,4-Diethylpyridine dicarboxylate |
|
|
ALX-270-372-M010 |
|
10 mg |
23.00 USD |
|
|
|
ALX-270-372-M025 |
|
25 mg |
53.00 USD |
|
|
|
ALX-270-372-M100 |
|
100 mg |
177.00 USD |
|
|
|
|
Dimethyloxalyl glycine |
|
|
ALX-270-371-M010 |
|
10 mg |
18.00 USD |
|
|
|
ALX-270-371-M050 |
|
50 mg |
72.00 USD |
|
|
|
ALX-270-371-M100 |
|
100 mg |
120.00 USD |
|
|
|
|
Echinomycin |
|
|
ALX-380-201-M001 |
|
1 mg |
80.00 USD |
|
|
|
ALX-380-201-M005 |
|
5 mg |
320.00 USD |
|
|
|
|
Emetine . dihydrochloride |
|
|
ALX-350-092-M050 |
|
50 mg |
10.00 USD |
|
|
|
|
Monoclonal Antibody to Ah Receptor Nuclear Translocator (2B10) |
|
|
ALX-804-108-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
Monoclonal Antibody to HIF-1α (mgc3) |
|
|
ALX-804-216-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
N-Oxalyl-D-alanine |
|
|
ALX-270-414-M010 |
|
10 mg |
80.00 USD |
|
|
|
ALX-270-414-M050 |
|
50 mg |
240.00 USD |
|
|
|
|
N-Oxalyl-L-alanine |
|
|
ALX-270-413-M010 |
|
10 mg |
60.00 USD |
|
|
|
ALX-270-413-M050 |
|
50 mg |
180.00 USD |
|
|
|
|
N-Oxalylglycine |
|
|
ALX-270-412-M010 |
|
10 mg |
40.00 USD |
|
|
|
ALX-270-412-M050 |
|
50 mg |
120.00 USD |
|
|
|
|
Polyclonal Antibody to Ah Receptor Nuclear Translocator (mouse) |
|
|
ALX-210-150-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
Polyclonal Antibody to HIF-1α |
|
|
ALX-210-069-C050 |
|
50 µg |
220.00 USD |
|
|
|
|
Polyclonal Antibody to HIF-2α (human) |
|
|
ALX-215-058-R200 |
|
200 µl |
267.00 USD |
|
|
|
|
Xanthohumol |
|
|
ALX-350-280-M005 |
|
5 mg |
135.00 USD |
|
|
|
|
YC-1 |
|
|
ALX-420-025-M001 |
|
1 mg |
20.00 USD |
|
|
|
ALX-420-025-M005 |
|
5 mg |
65.00 USD |
|
|
|
ALX-420-025-M025 |
|
25 mg |
260.00 USD |
|
|
|
 |
|
